In Vitro Biofilm Formation by Malassezia pachydermatis Isolates and Its Susceptibility to Azole Antifungals
Open Access
- 15 November 2022
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 8 (11) , 1209
Abstract
The yeast Malassezia pachydermatis, an opportunistic pathogen that inhabits the skin of various domestic and wild animals, is capable of producing a biofilm that plays an important role in antifungal resistance. The aim of this research study was to find the intensity of biofilm production by M. pachydermatis strains isolated from the ear canal of healthy dogs, and to determine the susceptibility of planktonic, adhered and biofilm-forming cells to three azole antifungals—itraco-nazole, voriconazole and posaconazole—that are most commonly used to treat Malassezia infections. Out of 52 isolates, 43 M. pachydermatis strains (82.7%) were biofilm producers with varying levels of intensity. For planktonic cells, the minimum inhibitory concentration (MIC) range was 0.125–2 µg/mL for itraconazole, 0.03–1 µg/mL for voriconazole and 0.03–0.25 µg/mL for posaconazole. Only two isolates (4.7%) were resistant to itraconazole, one strain (2.3%) to voriconazole and none to posaconazole. For adhered cells and the mature biofilm, the following MIC ranges were found: 0.25–16 µg/mL and 4–16 µg/mL for itraconazole, 0.125–8 µg/mL and 0.25–26 µg/mL for voriconazole, and 0.03–4 µg/mL and 0.25–16 µg/mL for posaconazole, respectively. The least resistance for adhered cells was observed for posaconazole (55.8%), followed by voriconazole (62.8%) and itraconazole (88.4%). The mature biofilm of M. pachydermatis showed 100% resistance to itraconazole, 95.3% to posaconazole and 83.7% to voriconazole. The results of this study show that higher concentrations of commonly used antifungal agents are needed to control infections caused by biofilm-forming strains of M. pachydermatis.Keywords
Funding Information
- Slovak Research and Development Agency (APVV-15-0377)
This publication has 27 references indexed in Scilit:
- Increased hydrophobicity inMalasseziaspecies correlates with increased proinflammatory cytokine expression in human keratinocytesMedical Mycology, 2012
- Biofilm formation of Malassezia pachydermatis from dogsVeterinary Microbiology, 2012
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012Journal of Clinical Microbiology, 2012
- Prevalence of Malassezia pachydermatis in dogs with suspected Malassezia dermatitis or otitis in SlovakiaActa Veterinaria Brno, 2011
- Colorimetric broth microdilution method for the antifungal screening of plant extracts against yeastsMethods, 2007
- Biofilm development by clinical isolates ofMalassezia pachydermatisMedical Mycology, 2007
- Verifiable single nucleotide polymorphisms of the internal transcribed spacer 2 region for the identification of 11 Malassezia speciesJournal of Dermatological Science, 2006
- Occurrence and Population Size of Malassezia spp. in the External Ear Canal of Dogs and Cats Both Healthy and with OtitisMycopathologia, 2005
- Biofilm-Forming Ability ofCandida albicansIs Unlikely To Contribute to High Levels of Oral Yeast Carriage in Cases of Human Immunodeficiency Virus InfectionJournal of Clinical Microbiology, 2003
- Factors associated with elevated cutaneous Malassezia p a chyderm a tis populations in dogs with Pruritic skin iseaseJournal of Small Animal Practice, 1996